AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 18822979
Drug: Chinese medicine
RxNorm normalized name: BUTYLENE GLYCOL 48 g in 240 mL CUTANEOUS TAPE [QIZHOUGUAI Chinese medicine patch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese medicine group
Trial: 15580060
Drug: Inspiratory muscle
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inspiratory muscle training (IMT) at 60% of individual sustained maximal inspiratory pressure (SMIP) for 10 weeks, three times weekly.
Trial: 15580060
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group exercised at 15% of SMIP for 10 weeks, three times weekly.
Trial: 11721719
Drug: GP IIb/IIIa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GP IIb/IIIa inhibitors, heparin according to TIMI 14 trial, and aspirin
Trial: 11721719
Drug: Placebo, rt-PA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, rt-PA 100 mg, standard heparin treatment, and aspirin
Trial: 11765119
Drug: GP IIb/IIIa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GP IIb/IIIa inhibitors
Trial: 7894208
Drug: D-Tryptophan-6 luteinizing
RxNorm normalized name: (6-D-Tryptophan)luteinizing hormone-releasing hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-Tryptophan-6 luteinizing hormone releasing hormone (D-Trp-6-LH-RH)
Trial: 30012107
Drug: eGFR 30-59
RxNorm normalized name: Egfr t790m inhibitor pf-06747775
DrugBank: Mavelertinib (DB16228)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: eGFR 30-59 ml/min/1.73 m2 (mild to moderate RI)
Trial: 30012107
Drug: eGFR <30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: eGFR <30 ml/min/1.73 m2 (severe RI)
Trial: 25054399
Drug: Local anesthetic
RxNorm normalized name: Local anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local anesthetic alone (1.5 mL of 1% preservative-free lidocaine)
Trial: 20354688
Drug: Paroxetine 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine 50 mg
Trial: 30868305
Drug: Spreader flaps
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Spreader flaps used in combination with spreader grafts (Group 1)
Trial: 12831522
Drug: Albendazole (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albendazole (400 mg/day for 5 days)
Trial: 10720024
Drug: Transdermal testosterone
RxNorm normalized name: testosterone Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal testosterone gel applied at four sites (left and right arms/shoulders and left and right abdomen)
Trial: 3937968
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no Mitomycin treatment)
Trial: 3937968
Drug: Mitomycin treatment
RxNorm normalized name: Mitomycin
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitomycin treatment
Trial: 25875940
Drug: Oral levodopa-carbidopa
RxNorm normalized name: carbidopa / levodopa
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral levodopa-carbidopa (LC-oral)
Trial: 23648698
Drug: Adrenalectomy and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adrenalectomy and Medical therapy (PA patients)
Trial: 19106196
Drug: Intracoronary infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary infusion of BMPC
Trial: 17404349
Drug: Placebo (subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (subcutaneous abdominal injections twice daily for 16 weeks)
Trial: 8822986
Drug: Enalaprilat (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalaprilat (1 mg)
Trial: 1444500
Drug: 2% topical
RxNorm normalized name: A/T/S 2% Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% topical minoxidil applied three times daily
Trial: 1444500
Drug: Prednisone (6-week
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (6-week taper)
Trial: 27688166
Drug: Bisphosphonate-coated implants
RxNorm normalized name: methylene diphosphonate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisphosphonate-coated implants
Trial: 27688166
Drug: Control (uncoated)
RxNorm normalized name: Afeditab CR
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control (uncoated) implants
Trial: 27688166
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of both implant types
Trial: 22442826
Drug: Vildagliptin 10
RxNorm normalized name: vildagliptin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vildagliptin 10 mg
Trial: 22442826
Drug: Vildagliptin 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vildagliptin 25 mg
Trial: 19736246
Drug: 9 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9 g/day MCI-196
Trial: 19736246
Drug: All doses
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All doses of MCI-196
Trial: 18932258
Drug: ABT-510 10
RxNorm normalized name: ABT-925
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT-510 10 mg twice daily
Trial: 18932258
Drug: ABT-510 25
RxNorm normalized name: ABT-925
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT-510 25 mg twice daily
Trial: 18932258
Drug: ABT-510 50
RxNorm normalized name: ABT-925
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT-510 50 mg twice daily
Trial: 7841965
Drug: Drug treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug treatment alone
Trial: 16187776
Drug: Behavior therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavior therapy after 6 months of drug treatment alone
Trial: 14507272
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g of oral calcium carbonate
Trial: 14507272
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g of oral calcium carbonate
Trial: 14507272
Drug: 4 g
RxNorm normalized name: CTX4 Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g of open-label calcium carbonate
Trial: 8777827
Drug: Low-protein diet
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-protein diet with 13.7 g of urea added (LP-U2)
Trial: 26872548
Drug: High-dose casein
RxNorm normalized name: caseins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose casein (HP)
Trial: 26872548
Drug: Low-dose casein
RxNorm normalized name: caseins
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose casein (LP)
Trial: 12213142
Drug: Aspirin therapy
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin therapy (low-risk/low-benefit)
Trial: 7609571
Drug: Sodium loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium loading (1 ml/kg of 10% NaCl infused for 15 minutes)
Trial: 57520
Drug: WRL 105
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WRL 105 strain live influenza vaccine
Trial: 21593114
Drug: teriparatide (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: teriparatide (20 μg sc once daily)
Trial: 21593114
Drug: alendronate (70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alendronate (70 mg once weekly)
Trial: 16333632
Drug: Both Enoxaparin
RxNorm normalized name: enoxaparin
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both Enoxaparin and Heparin
Trial: 11084176
Drug: Intranasal 17
RxNorm normalized name: NALOXONE RESCUE KIT INTRANASAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal 17 beta‐E2, 300 microg daily
Trial: 9333058
Drug: Single-dose chlorproguanil-dapsone
RxNorm normalized name: Dapsone
DrugBank: Dapsone (DB00250)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-dose chlorproguanil-dapsone
Trial: 8437527
Drug: SBT/AMP 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SBT/AMP 1 g/2 g t.i.d. (n=35 clinically evaluable)
Trial: 8437527
Drug: CXM 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CXM 1.5 g t.i.d. (n=35 clinically evaluable)
Trial: 2875812
Drug: Nadolol (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nadolol (40 mg bid)
Trial: 29635061
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg phenylephrine HCl combined with 650 mg acetaminophen, fasted
Trial: 29635061
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg phenylephrine HCl, fed
Trial: 26616001
Drug: Ketorolac nasal
RxNorm normalized name: ketorolac Nasal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac nasal spray 31.5 mg
Trial: 26616001
Drug: Oxycodone/ibuprofen 5/400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone/ibuprofen 5/400 mg
Trial: 26616001
Drug: Oxycodone/APAP 5/325
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone/APAP 5/325 mg
Trial: 26616001
Drug: Ketorolac nasal
RxNorm normalized name: ketorolac Nasal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketorolac nasal spray
Trial: 26616001
Drug: Tramadol HCl/APAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol HCl/APAP 75/650 mg
Trial: 26616001
Drug: Tramadol HCl/APAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol HCl/APAP 37.5/325 mg
Trial: 24585406
Drug: Pemetrexed (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pemetrexed (500 mg/m2) and carboplatin (AUC=5) followed by gefitinib (250 mg/day) for 6 months
Trial: 24585406
Drug: Pemetrexed (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pemetrexed (500 mg/m2) and carboplatin (AUC=5) alone
Trial: 23109900
Drug: Genotypes of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Genotypes of ACAT‐1 CC; ACAT‐1 AA and CC
Trial: 8669221
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of sufentanil of 15 micrograms/h
Trial: 8669221
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of sufentanil of 30 micrograms/h
Trial: 2148735
Drug: Chandonium iodide
RxNorm normalized name: Echothiophate Iodide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chandonium iodide 0.25 mg/kg
Trial: 29158123
Drug: Necitumumab continuation
RxNorm normalized name: Necitumumab
DrugBank: Necitumumab (DB09559)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Necitumumab continuation therapy
Trial: 28404091
Drug: Tenofovir disoproxil
RxNorm normalized name: Tenofovir Disoproxil
DrugBank: Tenofovir disoproxil (DB00300)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tenofovir disoproxil fumarate (300 mg)
Trial: 17493710
Drug: Flu vaccine
RxNorm normalized name: flu vaccine 2012 (18-64yrs)/PF 27 mcg/0.1 mL INTRADERM SYRINGE (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flu vaccine plus 10 microg IMP321
Trial: 17493710
Drug: Flu vaccine
RxNorm normalized name: flu vaccine 2012 (18-64yrs)/PF 27 mcg/0.1 mL INTRADERM SYRINGE (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flu vaccine plus 30 microg IMP321
Trial: 17493710
Drug: Flu vaccine
RxNorm normalized name: flu vaccine 2012 (18-64yrs)/PF 27 mcg/0.1 mL INTRADERM SYRINGE (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flu vaccine plus 100 microg IMP321
Trial: 17493710
Drug: Flu vaccine
RxNorm normalized name: flu vaccine 2012 (18-64yrs)/PF 27 mcg/0.1 mL INTRADERM SYRINGE (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flu vaccine plus saline control
Trial: 16179039
Drug: Total Intravenous
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total Intravenous Anaesthesia (TIVA, n = 19)
Trial: 25555797
Drug: Intranasal fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intranasal fentanyl
Trial: 1713985
Drug: benazepril 10
RxNorm normalized name: benazepril 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: benazepril 10 mg twice daily (b.i.d.) for 2 weeks
Trial: 11913804
Drug: Magnesium sulphate
RxNorm normalized name: Magnesium sulphate
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium sulphate (30 mg kg(‐1) bolus followed by 0.5 g h(‐1) infusion for 20 hours)
Trial: 11913804
Drug: Isotonic sodium
RxNorm normalized name: ISOTONIC SODIUM CHLORIDE SOLUTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic sodium chloride solution (same volume as magnesium)
Trial: 2031797
Drug: iohexol 300
RxNorm normalized name: IOHEXOL 300MG/ML INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iohexol 300 mg I/ml (690 mosm/kg H2O)
Trial: 31608551
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg pregabalin
Trial: 31982359
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg pregabalin
Trial: 31163544
Drug: Compound or
RxNorm normalized name: Soma Compound Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compound or multi-drug resistant bacteria group
Trial: 31163544
Drug: All groups
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All groups compared to compound or multi-drug resistant bacteria group
Trial: 9097895
Drug: Testosterone (50,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone (50, 100, and 200 mg)
Trial: 8474402
Drug: 9 g
RxNorm normalized name: Publix Pen Needle 29 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9 g fish oil (3.15 g n-3 fatty acids per day)
Trial: 8474402
Drug: 9 g
RxNorm normalized name: Publix Pen Needle 29 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 9 g olive oil
Trial: 31356713
Drug: CBT +
RxNorm normalized name: Cannabidiol
DrugBank: Cannabidiol (DB09061)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: CBT + medication
Trial: 31356713
Drug: Treatment response
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment response and remission
Trial: 29231499
Drug: Combination group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination group (acupuncture plus ginger moxibustion at Heding EX-LE 2)
Trial: 15247013
Drug: Vitamin E,
RxNorm normalized name: GRx Vitamin E, topical cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin E, 300 mg/day
Trial: 15247013
Drug: Multivitamin, two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multivitamin, two tablets t.i.d.
Trial: 15247013
Drug: Immun‐Age 6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immun‐Age 6 g/day nocte
Trial: 8452189
Drug: Single-dose fleroxacin
RxNorm normalized name: fleroxacin
DrugBank: Fleroxacin (DB04576)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose fleroxacin (400 mg)
Trial: 8452189
Drug: 7-day fleroxacin
RxNorm normalized name: fleroxacin
DrugBank: Fleroxacin (DB04576)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-day fleroxacin (200 mg once a day)
Trial: 31740197
Drug: EPA (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPA (1 g per day for 6 days)
Trial: 31740197
Drug: DHA (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHA (1 g per day for 6 days)
Trial: 27635620
Drug: Preradiation chemotherapy
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preradiation chemotherapy with cisplatin, etoposide, cyclophosphamide, and vincristine followed by craniospinal radiation (CSI)
Trial: 14667998
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg of oestradiol
Trial: 10923059
Drug: Critical tests
RxNorm normalized name: Critic-Aid Clear
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Critical tests administered at the beginning and end of the session
Trial: 10923059
Drug: Critical tests
RxNorm normalized name: Critic-Aid Clear
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Critical tests administered only once, at the end of the session
Trial: 20598123
Drug: Supervised implementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supervised implementation of the oral health care guideline and daily oral health care protocol
Trial: 20840223
Drug: Non-supervised implementation
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-supervised implementation of the oral health care guideline
Trial: 17236474
Drug: Assistive technology
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Assistive technology supplement to the School Function Assessment
Trial: 15244185
Drug: 150 mg/m2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg/m2 irinotecan once a week for four weeks followed by a two-week drug-free interval
Trial: 11220295
Drug: Rosiglitazone 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone 1.0 mg b.i.d.
Trial: 11220295
Drug: Rosiglitazone 2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone 2.0 mg b.i.d.
Trial: 2861523
Drug: J5 antibody
FDA approved: no
EMA approved: no
PMDA approved: no
Description: J5 antibody recipients
Trial: 30515431
Drug: Azithromycin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (10 mg/kg on day 1 and then 5 mg/kg once daily for 4 days)
Trial: 23018908
Drug: Fluticasone furoate/vilanterol
RxNorm normalized name: fluticasone furoate/vilanterol 100/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone furoate/vilanterol (100/25 μg)
Trial: 21926181
Drug: Anthocyanins (320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anthocyanins (320 mg) in short-term study
Trial: 21926181
Drug: Anthocyanins (320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anthocyanins (320 mg/day) in long-term study
Trial: 21926181
Drug: Anthocyanins with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anthocyanins with NO-cGMP inhibitors
Trial: 12911777
Drug: Oral challenges
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral challenges with peanut
Trial: 12911777
Drug: Oral challenges
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral challenges with milk
Trial: 12911777
Drug: Oral challenges
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral challenges with peanut oil
Trial: 3281702
Drug: Preference for
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preference for treatment
Trial: 22872218
Drug: Bisphosphonate (17.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisphosphonate (17.5 mg weekly oral risedronate)
Trial: 12791113
Drug: 0.7 ml.kg-1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.7 ml.kg-1 of 0.175% bupivacaine with 1 : 200 000 epinephrine
Trial: 12791113
Drug: 1.0 ml.kg-1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 ml.kg-1 of 0.175% bupivacaine with 1 : 200 000 epinephrine
Trial: 12791113
Drug: 1.3 ml.kg-1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.3 ml.kg-1 of 0.175% bupivacaine with 1 : 200 000 epinephrine
Trial: 12791113
Drug: 0.7 ml.kg-1,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.7 ml.kg-1, 1.0 ml.kg-1, 1.3 ml.kg-1 of 0.175% bupivacaine with 1 : 200 000 epinephrine
Trial: 1398281
Drug: Calcium Heparin
RxNorm normalized name: HEPARIN CALCIUM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium Heparin (5000 IU subcutaneously twice daily beginning 2 hours before surgery)
Trial: 6758747
Drug: Calcium Heparin
RxNorm normalized name: HEPARIN CALCIUM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium Heparin
Trial: 3912189
Drug: Vindeburnol 30,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vindeburnol 30, 60 or 90 mg/d
Trial: 27888448
Drug: Topical clobetasol
RxNorm normalized name: clobetasol Topical Foam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical clobetasol propionate 0.05% cream under occlusion with silicone dressing
Trial: 16799234
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg edaravone intravenously just before reperfusion
Trial: 11125896
Drug: Health worker
RxNorm normalized name: Apis cerana worker secretion preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Health worker training and STD syndrome packets (containing recommended drugs, condoms, partner notification cards, and information leaflets)
Trial: 3731680
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution placebo
Trial: 31908513
Drug: Wash+lotion
RxNorm normalized name: Zencia Wash
DrugBank: Octasulfur (DB09353)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wash+lotion
Trial: 31908513
Drug: Water+lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water+lotion
Trial: 30152116
Drug: Dual induction
RxNorm normalized name: Tums Dual Action
DrugBank: Alginic acid (DB13518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual induction therapy (rATG combined with either daclizumab or alemtuzumab) with planned early corticosteroid withdrawal
Trial: 15580349
Drug: Alendronate (70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate (70 mg/week)
Trial: 19216650
Drug: Nicardipine prolonged-release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicardipine prolonged-release implants (NPRIs)
Trial: 1742754
Drug: Saline (control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (control group) administered via i.v. infusion starting 30 min before APO administration.
Trial: 28902040
Drug: Rifaximin 550
RxNorm normalized name: rifAXIMin 550 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifaximin 550 mg administered twice daily for 12 weeks